Parallel Advisors’s Iovance Biotherapeutics IOVA Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $148 | Hold |
86
| – | – | ﹤0.01% | 3409 |
|
|
2025
Q1 | $286 | Sell |
86
-251
| -74% | -$835 | ﹤0.01% | 3320 |
|
|
2024
Q4 | $2.49K | Buy |
337
+153
| +83% | +$1.13K | ﹤0.01% | 2872 |
|
|
2024
Q3 | $1.73K | Sell |
184
-129
| -41% | -$1.21K | ﹤0.01% | 2903 |
|
|
2024
Q2 | $2.51K | Buy |
313
+205
| +190% | +$1.64K | ﹤0.01% | 2728 |
|
|
2024
Q1 | $1.6K | Hold |
108
| – | – | ﹤0.01% | 2857 |
|
|
2023
Q4 | $878 | Sell |
108
-477
| -82% | -$3.88K | ﹤0.01% | 2965 |
|
|
2023
Q3 | $2.66K | Buy |
585
+384
| +191% | +$1.75K | ﹤0.01% | 2726 |
|
|
2023
Q2 | $1.42K | Sell |
201
-35
| -15% | -$246 | ﹤0.01% | 2850 |
|
|
2023
Q1 | $1.44K | Buy |
236
+16
| +7% | +$98 | ﹤0.01% | 2864 |
|
|
2022
Q4 | $1.41K | Sell |
220
-316
| -59% | -$2.02K | ﹤0.01% | 2808 |
|
|
2022
Q3 | $5K | Buy |
536
+26
| +5% | +$243 | ﹤0.01% | 2277 |
|
|
2022
Q2 | $6K | Buy |
510
+252
| +98% | +$2.97K | ﹤0.01% | 2168 |
|
|
2022
Q1 | $4K | Sell |
258
-395
| -60% | -$6.12K | ﹤0.01% | 2362 |
|
|
2021
Q4 | $12K | Sell |
653
-37
| -5% | -$680 | ﹤0.01% | 2022 |
|
|
2021
Q3 | $17K | Buy |
690
+334
| +94% | +$8.23K | ﹤0.01% | 1804 |
|
|
2021
Q2 | $9K | Buy |
356
+277
| +351% | +$7K | ﹤0.01% | 2025 |
|
|
2021
Q1 | $3K | Buy |
79
+34
| +76% | +$1.29K | ﹤0.01% | 2356 |
|
|
2020
Q4 | $2K | Hold |
45
| – | – | ﹤0.01% | 2297 |
|
|
2020
Q3 | $1K | Hold |
45
| – | – | ﹤0.01% | 2426 |
|
|
2020
Q2 | $1K | Buy |
+45
| New | +$1K | ﹤0.01% | 2322 |
|